IL102227A0 - Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,their preparation and pharmaceutical compositions containing them - Google Patents
Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL102227A0 IL102227A0 IL102227A IL10222792A IL102227A0 IL 102227 A0 IL102227 A0 IL 102227A0 IL 102227 A IL102227 A IL 102227A IL 10222792 A IL10222792 A IL 10222792A IL 102227 A0 IL102227 A0 IL 102227A0
- Authority
- IL
- Israel
- Prior art keywords
- dihydropyrano
- pyridines
- substituted
- aminomethyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Polyesters Or Polycarbonates (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4120322A DE4120322A1 (de) | 1991-06-20 | 1991-06-20 | Aminomethyl-substituierte 2,3-dihydropyrano(2,3-b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
Publications (1)
Publication Number | Publication Date |
---|---|
IL102227A0 true IL102227A0 (en) | 1993-01-14 |
Family
ID=6434336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL102227A IL102227A0 (en) | 1991-06-20 | 1992-06-17 | Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,their preparation and pharmaceutical compositions containing them |
Country Status (24)
Country | Link |
---|---|
US (1) | US5250540A (xx) |
EP (1) | EP0519291B1 (xx) |
JP (1) | JP3135170B2 (xx) |
KR (1) | KR930000520A (xx) |
CN (1) | CN1067656A (xx) |
AT (1) | ATE147388T1 (xx) |
AU (1) | AU649331B2 (xx) |
CA (1) | CA2071398A1 (xx) |
CZ (1) | CZ177892A3 (xx) |
DE (2) | DE4120322A1 (xx) |
DK (1) | DK0519291T3 (xx) |
ES (1) | ES2095984T3 (xx) |
FI (1) | FI922874A (xx) |
GR (1) | GR3022557T3 (xx) |
HU (1) | HU209890B (xx) |
IE (1) | IE922004A1 (xx) |
IL (1) | IL102227A0 (xx) |
MX (1) | MX9202983A (xx) |
NO (1) | NO922198L (xx) |
NZ (1) | NZ243191A (xx) |
RU (1) | RU2044737C1 (xx) |
SK (1) | SK177892A3 (xx) |
TW (1) | TW221439B (xx) |
ZA (1) | ZA924517B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0714395T3 (da) * | 1993-08-19 | 1999-10-11 | Janssen Pharmaceutica Nv | Substituerede dihydropyranopyridiner med vasokonstriktoraktivitet |
WO1999006341A1 (en) | 1997-07-31 | 1999-02-11 | Dupont Pharmaceuticals Company | A process for the preparation of cyclopropylacetylene |
US6235957B1 (en) | 1998-06-29 | 2001-05-22 | Dupont Pharmaceuticals Company | Process for the preparation of cyclopropylacetylene |
AU4698299A (en) | 1998-06-30 | 2000-01-17 | Du Pont Pharmaceuticals Company | 5-HT7 receptor antagonists |
US6359164B1 (en) | 1998-10-01 | 2002-03-19 | Zhe Wang | Process for the preparation of cyclopropylacetylene |
US6288297B1 (en) | 1998-10-01 | 2001-09-11 | Dupont Pharmaceuticals Company | Process for the preparation of cyclopropylacetylene |
JP2001131177A (ja) * | 1999-11-08 | 2001-05-15 | Ohara Yakuhin Kogyo Kk | ジベンズ[c,f]イミダゾ[1,5−a]アゼピンの製造方法及びその製造中間体 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR930005004B1 (ko) * | 1985-04-15 | 1993-06-11 | 쟈안센 파아마슈우티카 엔. 부이. | 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법 |
US4748182A (en) * | 1986-03-05 | 1988-05-31 | Merrell Dow Pharmaceuticals Inc. | Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents |
DE3718317A1 (de) * | 1986-12-10 | 1988-06-16 | Bayer Ag | Substituierte basische 2-aminotetraline |
DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
CA2015296C (en) * | 1989-05-31 | 2001-08-07 | Karnail Atwal | Pyranyl cyanoguanidine derivatives |
EP0429341A3 (en) * | 1989-11-20 | 1991-11-13 | Rhone-Poulenc Sante | Heterocyclic derivatives, their preparation and pharmaceuticals containing them |
FR2662696A2 (fr) * | 1989-12-13 | 1991-12-06 | Rhone Poulenc Sante | Antagonistes de la serotonine, leur preparation et medicaments les contenant. |
-
1991
- 1991-06-20 DE DE4120322A patent/DE4120322A1/de not_active Withdrawn
-
1992
- 1992-05-29 TW TW081104193A patent/TW221439B/zh active
- 1992-06-03 AU AU17392/92A patent/AU649331B2/en not_active Ceased
- 1992-06-04 NO NO92922198A patent/NO922198L/no unknown
- 1992-06-09 EP EP92109625A patent/EP0519291B1/de not_active Expired - Lifetime
- 1992-06-09 DK DK92109625.1T patent/DK0519291T3/da active
- 1992-06-09 AT AT92109625T patent/ATE147388T1/de not_active IP Right Cessation
- 1992-06-09 DE DE59207824T patent/DE59207824D1/de not_active Expired - Fee Related
- 1992-06-09 ES ES92109625T patent/ES2095984T3/es not_active Expired - Lifetime
- 1992-06-11 US US07/896,956 patent/US5250540A/en not_active Expired - Lifetime
- 1992-06-11 CZ CS921778A patent/CZ177892A3/cs unknown
- 1992-06-11 SK SK1778-92A patent/SK177892A3/sk unknown
- 1992-06-17 IL IL102227A patent/IL102227A0/xx unknown
- 1992-06-17 CA CA002071398A patent/CA2071398A1/en not_active Abandoned
- 1992-06-18 FI FI922874A patent/FI922874A/fi unknown
- 1992-06-18 NZ NZ243191A patent/NZ243191A/en unknown
- 1992-06-18 MX MX9202983A patent/MX9202983A/es unknown
- 1992-06-19 KR KR1019920010662A patent/KR930000520A/ko not_active Application Discontinuation
- 1992-06-19 RU SU925011988A patent/RU2044737C1/ru active
- 1992-06-19 HU HU9202066A patent/HU209890B/hu not_active IP Right Cessation
- 1992-06-19 JP JP04186017A patent/JP3135170B2/ja not_active Expired - Fee Related
- 1992-06-19 ZA ZA924517A patent/ZA924517B/xx unknown
- 1992-06-20 CN CN92104841A patent/CN1067656A/zh active Pending
- 1992-07-01 IE IE200492A patent/IE922004A1/en not_active Application Discontinuation
-
1997
- 1997-02-12 GR GR970400247T patent/GR3022557T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU649331B2 (en) | 1994-05-19 |
EP0519291B1 (de) | 1997-01-08 |
DK0519291T3 (da) | 1997-06-09 |
HU9202066D0 (en) | 1992-09-28 |
JP3135170B2 (ja) | 2001-02-13 |
SK177892A3 (en) | 1995-03-08 |
IE922004A1 (en) | 1992-12-30 |
KR930000520A (ko) | 1993-01-15 |
FI922874A (fi) | 1992-12-21 |
HUT64959A (en) | 1994-03-28 |
JPH05202054A (ja) | 1993-08-10 |
TW221439B (xx) | 1994-03-01 |
CA2071398A1 (en) | 1992-12-21 |
US5250540A (en) | 1993-10-05 |
RU2044737C1 (ru) | 1995-09-27 |
DE4120322A1 (de) | 1992-12-24 |
HU209890B (en) | 1994-11-28 |
ATE147388T1 (de) | 1997-01-15 |
GR3022557T3 (en) | 1997-05-31 |
NO922198D0 (no) | 1992-06-04 |
FI922874A0 (fi) | 1992-06-18 |
ZA924517B (en) | 1993-03-31 |
AU1739292A (en) | 1992-12-24 |
CZ177892A3 (en) | 1993-02-17 |
EP0519291A1 (de) | 1992-12-23 |
MX9202983A (es) | 1992-12-01 |
DE59207824D1 (de) | 1997-02-20 |
ES2095984T3 (es) | 1997-03-01 |
CN1067656A (zh) | 1993-01-06 |
NZ243191A (en) | 1994-04-27 |
NO922198L (no) | 1992-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL103545A0 (en) | 2-aminomethyl-chromans,their preparation and pharmaceutical compositions containing them | |
IL97912A0 (en) | Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
IL104006A (en) | Azaheterocyclylmethyl-chromans their preparation and pharmaceutical compositions containing them | |
IL111365A (en) | (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans their preparation and pharmaceutical compositions containing them | |
HUP9701096A3 (en) | Use of benzenesulfonamides for the preparation of pharmaceutical compositions treating disorders of the central nervous system, novel derivatives, process for their preparation and pharmaceutical compositions containing them | |
IL96167A0 (en) | Imidazo(4,5-b)quinolinyloxyalkanoic acid amides,their preparation and pharmaceutical compositions containing them | |
HUT77667A (hu) | Imidazo[4,5-c]kinolin-aminok, ezeket tartalmazó gyógyászati készítmények, és alkalmazásuk | |
IL64091A (en) | Arylimidazo(1,2-a)pyridine acetamide derivatives,their preparation and pharmaceutical compositions containing them | |
ZA81219B (en) | Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them | |
PT86186A (en) | Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same | |
IL79992A (en) | Pyrimidineaminopiperidino-benzimidazoles and-imidazo-(4,5-b)pyridines,process for their preparation and pharmaceutical compositions comprising them | |
IL102227A0 (en) | Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,their preparation and pharmaceutical compositions containing them | |
IL93988A0 (en) | Substituted 1,8-naphthyridines,their preparation and medicaments comprising them | |
IL104005A0 (en) | Piperidylmethyl-substituted chroman derivatives,their preparation and pharmaceutical compositions containing them | |
HU901386D0 (en) | Antidotes comprising 2,3-substituted 1,8-naphthyridines, antidoted herbicidal compositions, and process for preparation of the active ingredients | |
IL95376A0 (en) | Pyrido(3,4-b)(1,4)-benzoxazepines,process for their preparation and their use as medicaments | |
HU901633D0 (en) | Process for the preparation of biphenyl derivatives and pharmaceutical compositions containing them | |
HUT45253A (en) | Process for producing imidazo/4,5-b/pyridin-2-one derivatives and pharmaceutical compositions containing them | |
IL89098A (en) | Amino- or cyclicamino-acyl substituted pyrido-(2,3-b) (1,4)-and thieno (3,4-b) (1,5) benzodiazepinones, their preparation and pharmaceutical compositions containing them | |
HUT49054A (en) | Process for producing pharmaceutical compositions absorbed through the derm and comprising pyrazolo(1,5-a) pyridine derivatives as active ingredient | |
PT85001A (en) | Process for the preparation of 2,3-dihydro-1-(8-methyl-1,2,4-triazolo ]4,3-b" pyridazin-6-yl)-4 (1h)-pyridinone and of pharmaceutical compositions containing the same | |
IS3938A (is) | Aðferð við framleiðslu nýrra pyrimídó [1',6':1,2]pyridó [3,4-b] indól afleiða og lyfjablandna sem innihalda þær | |
PT73145B (en) | Process for the preparation of 7,8,9,10-tetrahydrofuro<3,2-e>pyrido<4,3-b>indole derivatives having effect on the central nervous system and their application in the preparation of pharmaceutical compositions having effect on the central nervous system | |
PT84310B (en) | Pyrrolo ]3,4-b" pyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them | |
ZA879552B (en) | Tetrahydropyrido(1,2-a).indole derivatives,process for their preparation and pharmaceutical composition containing them |